PARP-1 and its associated nucleases in DNA damage response Y Wang, W Luo, Y Wang DNA repair 81, 102651, 2019 | 183 | 2019 |
Hypoxia-induced WSB1 promotes the metastatic potential of osteosarcoma cells J Cao, Y Wang, R Dong, G Lin, N Zhang, J Wang, N Lin, Y Gu, L Ding, ... Cancer Research 75 (22), 4839-4851, 2015 | 66 | 2015 |
The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial–mesenchymal transition induced by hypoxia and TGF-β1 G Lin, R Gai, Z Chen, Y Wang, S Liao, R Dong, H Zhu, Y Gu, Q He, ... European journal of pharmacology 729, 45-53, 2014 | 56 | 2014 |
CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors Y Wang, Y Chen, L Bao, B Zhang, JE Wang, A Kumar, C Xing, Y Wang, ... Cancer research 80 (18), 3880-3891, 2020 | 42 | 2020 |
SIRT1 promotes metastasis of human osteosarcoma cells N Zhang, T Xie, M Xian, YJ Wang, HY Li, MD Ying, ZM Ye Oncotarget 7 (48), 79654, 2016 | 36 | 2016 |
MIF is a 3’flap nuclease that facilitates DNA replication and promotes tumor growth Y Wang, Y Chen, C Wang, M Yang, Y Wang, L Bao, JE Wang, BW Kim, ... Nature communications 12 (1), 2954, 2021 | 26 | 2021 |
USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α W Huang, X Liu, Y Zhang, M Deng, G Li, G Chen, L Yu, L Jin, T Liu, ... Journal of Cellular Physiology 237 (4), 2211-2219, 2022 | 20 | 2022 |
The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment Y Wang, X Liu, W Huang, J Liang, Y Chen Pharmacology & therapeutics 240, 108303, 2022 | 19 | 2022 |
MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury Z Ruan, Q Lu, JE Wang, M Zhou, S Liu, H Zhang, A Durvasula, Y Wang, ... Cellular and Molecular Life Sciences, 1-20, 2021 | 16 | 2021 |
Romance of the three kingdoms in hypoxia: HIFs, epigenetic regulators, and chromatin reprogramming Y Chen, M Liu, Y Niu, Y Wang Cancer Letters 495, 211-223, 2020 | 14 | 2020 |
ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells M Luo, L Bao, Y Chen, Y Xue, Y Wang, B Zhang, C Wang, CD Corley, ... Science advances 8 (28), eabn5295, 2022 | 12 | 2022 |
ZMYND8 expression in breast cancer cells blocks T-lymphocyte surveillance to promote tumor growth Y Wang, M Luo, Y Chen, Y Wang, B Zhang, Z Ren, L Bao, Y Wang, ... Cancer research 81 (1), 174-186, 2021 | 12 | 2021 |
The multifaceted functions of RNA helicases in the adaptive cellular response to hypoxia: From mechanisms to therapeutics Y Wang, G Li, M Deng, X Liu, W Huang, Y Zhang, M Liu, Y Chen Pharmacology & Therapeutics 221, 107783, 2021 | 7 | 2021 |
UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation Y Wang, X Liu, M Wang, Y Wang, S Wang, L Jin, M Liu, J Zhou, Y Chen Oncogene 42 (46), 3394-3406, 2023 | 4 | 2023 |